Results 181 to 190 of about 12,655 (217)

Atypical hemolytic-uremic syndrome after COVID-19 vaccine: A case report. [PDF]

Immun Inflamm Dis
Campos MAG, Ataídes RJC, Ferreira MC, Alves AS, Silva GEB.   +4 more
europepmc   +1 more source

High prevalence of the hotspot complement factor I p.Ile357Met pathogenic variant in Tunisian atypical hemolytic uremic syndrome patients: report of three new cases and review of the literature. [PDF]

Front Immunol
Tajouri A, Ayadi I, BenBrahim R, Mami I, Boussetta A, Jlajla H, Zerzeri Y, Arbi Sassi H, Ben Sassi J, Sahli H, Laadhar L, Gargah T, Zouaghi MK, Kallel Sellami M.   +13 more
europepmc   +1 more source

Significance of complement system diagnostics in thrombotic microangiopathies [PDF]

, 2017
Csuka, Dorottya, Miklaszewska, Monika, Prohászka, Zoltán, Szilágyi, Ágnes, Zachwieja, Katarzyna   +4 more
core  

Exploring the Intersection of Atypical Hemolytic Uremic Syndrome and Substance Use: A Comprehensive Narrative Review. [PDF]

Cureus
Akbariansaravi A, Dekhne A, Dhamelia A, Mekhail M.   +3 more
europepmc   +1 more source

A Unique Presentation of Atypical Hemolytic Uremic Syndrome With Unilateral Blindness and Ischemic Stroke: A Case Report. [PDF]

Cureus
Girdhar K, Bansal DP, Rijhwani P, Gupta M, Girdhar N.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Atypical Hemolytic–Uremic Syndrome

New England Journal of Medicine, 2009
The hemolytic–uremic syndrome, which is characterized by nonimmune hemolytic anemia, thrombocytopenia, and renal impairment, occurs most frequently in young children. Most cases are secondary to infection with Escherichia coli O157:H7 and other Shiga-toxin–producing strains.
Marina, Noris, Giuseppe, Remuzzi
openaire   +4 more sources

Atypical hemolytic uremic syndrome

Current Opinion in Hematology, 2010
The last few years revealed a molecular distinction between thrombotic thrombocytopenic purpura, a disease characterized by a lack of ADAMTS13 activity, and atypical hemolytic uremic syndrome (aHUS), a disease of complement overactivation. Many different predisposing genetic factors resulting in complement overactivation have been described in aHUS ...
Kavanagh D, Goodship THJ
openaire   +3 more sources

Atypical hemolytic uremic syndrome

Pediatrics International, 1995
AbstractThe pathogenesis of atypical uremic syndrome (HUS), which is rarely encountered in childhood, is poorly understood and its mortality and morbidity rates are high. A wide variety of therapeutic approaches has been attempted and the literature contains numerous conflicting reports about the results of these approaches.
İRKEN G., KAVUKÇU S., OLGUN N., GÜÇLÜ A.   +3 more
openaire   +3 more sources

Atypical hemolytic uraemic syndrome

Medicina Clínica (English Edition), 2015
The hemolytic uremic syndrome (HUS) is a clinical entity characterized by thrombocytopenia, non-immune hemolytic anemia and renal impairment. Kidney pathology shows thrombotic microangiopathy (TMA) with endothelial cell injury leading to thrombotic occlusion of arterioles and capillaries.
Miquel, Blasco Pelicano, Santiago, Rodríguez de Córdoba, Josep M, Campistol Plana   +2 more
openaire   +2 more sources

Plasmatherapy in Atypical Hemolytic Uremic Syndrome

Seminars in Thrombosis and Hemostasis, 2010
Plasmatherapy has become empirically first-line treatment in atypical hemolytic uremic syndrome (aHUS), although no prospective controlled trials have been conducted. Patients with mutations that induce complete or partial factor H (FH) quantitative deficiency may be controlled by plasma infusions (PI), but plasma exchanges appear more efficient than ...
Chantal, Loirat, Arnaud, Garnier, Anne-Laure, Sellier-Leclerc, Theresa, Kwon   +3 more
openaire   +2 more sources